Chair Shannon O’Brien Issues Statements Regarding Her Priorities for the Cannabis Control Commission

WORCESTER—Massachusetts Cannabis Control Commission (Commission) Chair Shannon O’Brien today announced her priorities for the agency as it continues to regulate the Commonwealth’s growing, $8 billion cannabis industry.

“Our mandate is to ensure that this industry is both safe and fair,” said Chair O’Brien, following the adjournment of the Commission’s public meeting on Wednesday, Oct. 1. “We must balance strong consumer protections with a regulatory framework that does not impose excessive costs on responsible business owners. By doing so, we can support a sustainable marketplace that benefits consumers, entrepreneurs, and communities alike.”

Following her return to the Commission on Sept. 18, the Chair stated that among her first orders of business are the reduction of unnecessary regulatory burdens for Marijuana Establishments and Medical Marijuana Treatment Centers, the strengthening of Independent Testing Laboratory (ITL) oversight to protect public health, and the advancement of meaningful reforms to the Social Equity Program (SEP) to ensure greater economic opportunities for communities that have been disproportionately harmed by the War on Drugs.

O’Brien highlighted concerns that overly complex or duplicative requirements create unnecessary costs for cannabis businesses, particularly small operators. She pledged to lead a comprehensive review of regulations to streamline compliance without sacrificing safety.

“Over-regulation can unintentionally shut out diverse new entrants and impedes all businesses from achieving economic success,” O’Brien said. “Our goal is smart regulation that protects the public while allowing businesses to succeed.”

O’Brien also announced that she will prioritize stronger oversight measures and standardization for ITLs, noting that protecting consumer health is central to the agency’s mission. By improving lab accountability, standardizing quality controls, and enhancing transparency, the Chair noted that the Commission can ensure that every cannabis product sold in Massachusetts meets the highest safety standards.

Chair O’Brien also reaffirmed her commitment to building a more inclusive industry that reflects the communities most harmed by past cannabis prohibition. She underscored the importance of expanding access to capital, technical assistance, and licensing opportunities for equity applicants.

“If we are serious about repairing historic inequities, we must make equity more than just a principle—we must make it a practice,” Chair O’Brien said. “The Commission has a responsibility not only to regulate but to lead. By reducing barriers, strengthening safeguards, and centering equity, we will grow an industry that Massachusetts can be proud of.”

The Commission’s next public meeting is slated Thursday, Oct. 9. To review the Oct. 1 public meeting, visit MassCannabisControl.com/Calendar and access the Microsoft Teams link for a video recording or review the Commission’s YouTube channel. For more information, visit MassCannabisControl.com, contact the Commission by phone (774-415-0200) or email (Commission@CCCMass.com), or follow the agency on Facebook, LinkedIn, and X.

###